These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Draft genome sequence of Fusobacterium nucleatum subsp. fusiforme ATCC 51190T. Park SN; Kong SW; Park MS; Lee JW; Cho E; Lim YK; Choi MH; Kim HS; Chang YH; Shin JH; Park HS; Choi SH; Kook JK J Bacteriol; 2012 Oct; 194(19):5445-6. PubMed ID: 22965077 [TBL] [Abstract][Full Text] [Related]
47. A survey of Cochrane K; Robinson AV; Holt RA; Allen-Vercoe E Microb Genom; 2020 Feb; 6(2):. PubMed ID: 31661053 [TBL] [Abstract][Full Text] [Related]
48. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis. Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341 [TBL] [Abstract][Full Text] [Related]
49. Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases. Gmür R; Munson MA; Wade WG Syst Appl Microbiol; 2006 Mar; 29(2):120-30. PubMed ID: 16464693 [TBL] [Abstract][Full Text] [Related]
53. Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis. Desvaux M; Khan A; Beatson SA; Scott-Tucker A; Henderson IR Biochim Biophys Acta; 2005 Jul; 1713(2):92-112. PubMed ID: 15993836 [TBL] [Abstract][Full Text] [Related]
54. Determination of the Role of Fusobacterium Nucleatum in the Pathogenesis in and Out the Mouth. Tefiku U; Popovska M; Cana A; Zendeli-Bedxeti L; Recica B; Spasovska-Gjorgovska A; Spasovski S Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2020 Jun; 41(1):87-99. PubMed ID: 32573481 [TBL] [Abstract][Full Text] [Related]
56. Akkermansia muciniphila inhibited the periodontitis caused by Fusobacterium nucleatum. Song B; Xian W; Sun Y; Gou L; Guo Q; Zhou X; Ren B; Cheng L NPJ Biofilms Microbiomes; 2023 Jul; 9(1):49. PubMed ID: 37460552 [TBL] [Abstract][Full Text] [Related]
57. Isolation and molecular identification of Fusobacterium nucleatum from Nigerian patients with oro-facial infections. Nwaokorie FO; Coker AO; Ogunsola FT; Avika-Campos MJ; Gaetti-Jardim E; Ayanbadejo PO; Umeizudike KA; Abdurrazaq OT West Afr J Med; 2011; 30(2):125-9. PubMed ID: 21984462 [TBL] [Abstract][Full Text] [Related]
58. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893 [TBL] [Abstract][Full Text] [Related]
59. Efficient gene transfer and targeted mutagenesis in Fusobacterium nucleatum. Kinder Haake S; Yoder S; Gerardo SH Plasmid; 2006 Jan; 55(1):27-38. PubMed ID: 16115683 [TBL] [Abstract][Full Text] [Related]
60. Autoinducer 2 of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens. Jang YJ; Choi YJ; Lee SH; Jun HK; Choi BK Arch Oral Biol; 2013 Jan; 58(1):17-27. PubMed ID: 22633049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]